Home » Topics » Regulatory » Patents

Patents
RSS

University of Queensland, Preveceutical Medical patent delta- and kappa-opioid receptor antagonists

Aug. 19, 2020

Zhejiang Hisun Pharmaceutical presents new RET inhibitors

Aug. 19, 2020

Jiangsu Vcare Pharmatech discovers JAK inhibitors

Aug. 19, 2020

New PD-1/PD-L1 and/or PD-L1/CD80 interaction inhibitors patented by Betta Pharmaceuticals

Aug. 19, 2020

BrightGene Bio-Medical Technology identifies Gly12Cys mutant GTPase KRAS inhibitors

Aug. 19, 2020

CSPC Zhongqi Pharmaceutical Technology describes PROTAC BRD4 degradation inducers

Aug. 18, 2020

New MAP2K1 inhibitors patented by Betta Pharmaceuticals

Aug. 18, 2020

Gargamel (Zhuhai) Biotech discovers JAK-1 inhibitors

Aug. 18, 2020

New CACNA2D ligands discovered at Sichuan Haisco Pharmaceutical

Aug. 18, 2020

Sichuan Kelun-Biotech Biopharmaceutical synthesizes new camptothecin derivatives

Aug. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...